Backing pioneers who are transforming the health industry from digital therapeutics through to biotechnology.
As the UK’s most active health investor, Octopus Ventures is committed to a better future: for the past 18 months we’ve been researching developments in the fertility sector.
Our latest insights and news
In the press
Writing in The Times Uzma Choudry explains why the vaccine model needs to change
Stopping pandemics requires humanitarian intentions, but until we disrupt the model that holds pharma accountable to profit, this will never come first.
As fertility rates continue to decline not everyone has access to treatment
The Telegraph reports on Kamran’s research into the funds raised by fertility startups looking at innovative ways to tackle the issue.
Will Gibbs reveals to TechCrunch how taboo healthcare subjects have huge potential markets
Cultural and institutional stigma has kept parts of healthcare out of sight and out of mind to all but the boldest entrepreneurs.
How tech will tackle health’s neglected problems
Will tells The New Scientist why we’re backing the tech pioneers who are tackling health’s biggest – but neglected – problems.
Elvie’s femtech revolution
The Telegraph reports on Femtech superstar, Tania Boler.
Mental health investment reaches record high
Forbes reports on Kamran’s research into an area that presents massive potential for innovators and disruptors.
Building a business is hard. So we’ve created a structure that best supports founders to face all challenges head on.